Defining Parameters That Modulate Susceptibility and Protection to Respiratory Murine Coronavirus MHV1 Infection
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2300434 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Elvia E Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Iowa, Iowa City, IA. Hauptthemen laut MEDLINE: Murine hepatitis virus, Sepsis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, BLRD VA.
Abstract (Originalsprache)
Patients infected with SARS-CoV-2 experience variable disease susceptibility, and patients with comorbidities such as sepsis are often hospitalized for COVID-19 complications. However, the extent to which initial infectious inoculum dose determines disease outcomes and whether this can be used for immunological priming in a genetically susceptible host has not been completely defined. We used an established SARS-like murine model in which responses to primary and/or secondary challenges with murine hepatitis virus type 1 (MHV-1) were analyzed. We compared the response to infection in genetically susceptible C3H/HeJ mice, genetically resistant C57BL/6J mice, and genetically diverse, variably susceptible outbred Swiss Webster mice. Although defined as genetically susceptible to MHV-1, C3H/HeJ mice displayed decreasing dose-dependent pathological changes in disease severity and lung infiltrate/edema, as well as lymphopenia. Importantly, an asymptomatic dose (500 PFU) was identified that yielded no measurable morbidity/mortality postinfection in C3H/HeJ mice. Polymicrobial sepsis induced via cecal ligation and puncture converted asymptomatic infections in C3H/HeJ and C57BL/6J mice to more pronounced disease, modeling the impact of sepsis as a comorbidity to β-coronavirus infection. We then used low-dose infection as an immunological priming event in C3H/HeJ mice, which provided neutralizing Ab-dependent, but not circulating CD4/CD8 T cell–dependent, protection against a high-dose MHV-1 early rechallenge. Together, these data define how infection dose, immunological status, and comorbidities modulate outcomes of primary and secondary β-coronavirus infections in hosts with variable susceptibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology, University of Iowa, Iowa City, IA.
- Interdisciplinary Program in Immunology, University of Iowa, Iowa City, IA.
- Department of Urology, University of Minnesota, Minneapolis, MN.
- Minneapolis Veterans Affairs Health Care System, Minneapolis, MN.
ORCID-Profile: Elvia E Silva, Mariah Hassert, Roger R Berton, Matthew G Smith, David K Meyerholz, Thomas S Griffith, John T Harty, Vladimir P Badovinac
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- BLRD VA
- NCI NIH HHS
- NIDDK NIH HHS
- HHS | NIH | National Institute of General Medical Sciences
- HHS | NIH | NIAID | Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- HHS | NIH | National Cancer Institute
Zitieren
APA
Silva, E. E., Moioffer, S. J., Hassert, M., Berton, R. R., Smith, M. G., van de Wall, S., Meyerholz, D. K., Griffith, T. S., Harty, J. T., & Badovinac, V. P. (2024). Defining Parameters That Modulate Susceptibility and Protection to Respiratory Murine Coronavirus MHV1 Infection. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300434
Vancouver
Silva EE, Moioffer SJ, Hassert M, Berton RR, Smith MG, van de Wall S, et al. Defining Parameters That Modulate Susceptibility and Protection to Respiratory Murine Coronavirus MHV1 Infection. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300434
BibTeX
@article{Silva2024,
author = {Silva, Elvia E and Moioffer, Steven J and Hassert, Mariah and Berton, Roger R and Smith, Matthew G and van de Wall, Stephanie and Meyerholz, David K and Griffith, Thomas S and Harty, John T and Badovinac, Vladimir P},
title = {Defining Parameters That Modulate Susceptibility and Protection to Respiratory Murine Coronavirus MHV1 Infection},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2300434}
}
EUVIMED